FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

36043811000001105: Mirtazapine 15mg orodispersible tablets (Medreich Plc) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Nov 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
111169201000001115 Mirtazapine 15mg orodispersible tablets (Medreich Plc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
111169301000001112 Mirtazapine 15mg orodispersible tablets (Medreich Plc) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mirtazapine 15mg orodispersible tablets (Medreich Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Medreich Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Medreich Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Medreich Plc) Is a Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) true Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Medreich Plc) Has active ingredient Mirtazapine true Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Medreich Plc) Has manufactured dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Medreich Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Medreich Plc) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Medreich Plc) Has specific active ingredient Mirtazapine true Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Medreich Plc) Has dispensed dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Medreich Plc) Has excipient Aspartame false Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Medreich Plc) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Medreich Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Mirtazapine 15mg orodispersible tablets (Medreich Plc) 30 tablet 2 x 15 tablets Has AMP True Mirtazapine 15mg orodispersible tablets (Medreich Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start